German pharma firm Bayer announces $62 billion offer for Monsanto

Bayer said on Monday that the offer represented a 37% premium over the closing price of Monsanto shares on May 9, before rumours of a planned bid emerged.

The corporate logo of Bayer is seen at the headquarters building in Caracas March 1, 2016. Image Source: Reuters/Marco Bello

German drugs and chemicals group Bayer AG said it had made an offer to buy US seeds company Monsanto Company for $122 per share in cash, or a total value of $62 billion (nearly Rs 4,12,470.5 crore), to create the world's biggest agricultural supplier.

Bayer said on Monday that the offer represented a 37% premium over the closing price of Monsanto shares on May 9, before rumours of a planned bid emerged.

Monsanto had disclosed last week that Bayer had made an unsolicited takeover offer for the group, triggering an investor backlash in which one of the German pesticides and drugs company's major shareholders called the move "arrogant empire-building".

TRENDING NOW

Bayer's offer values Monsanto at 15.8 times its 12-month earnings before interest, tax, depreciation and amortisation (EBITDA) as of February 29.

Bayer said it planned to finance the deal with a combination of debt and equity, which would include a rights offering.

It expects annual earnings contributions from synergies of around $1.5 billion (nearly Rs 9,979.13 crore) after three years, plus additional future benefits from integrated offerings.

TAGS: